CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cello Health PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cello Health PLC
Queens House, 8-9 Queen Street
Phone: +44 2078128468p:+44 2078128468 London, EC4N 1SP  United Kingdom Fax: +44 2072535376f:+44 2072535376

This company was Merged or Acquired on 8/11/2020.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201912/31/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Non-Executive Chairman ChristopherJones 63 11/5/2018 10/17/2016
Chief Executive, Executive Director MarkScott 5/5/2004 5/5/2004
Group Finance Director, Executive Director MarkBentley 1/1/2019 5/1/2005
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Advantage Healthcare Inc.
Cello Health BioConsulting
CLL
11 additional Business Names available in full report.

General Information
Number of Employees: 948 (As of 12/31/2019)
Outstanding Shares: 106,230,196 (As of 12/31/2019)
Stock Exchange: LON
Fax Number: +44 2072535376


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023